Oral Syringes Market Size, Share, and Trends 2024 to 2033

Oral Syringes Market (By Capacity: Small Volume Syringe (1 to 10 ml), Medium Volume Syringe (10 to 20 ml), Large Volume Syringe (above 20ml); By Order Type: OTC, Prescription; By Sales Channel: Institutional Sales, Hospitals/Clinics, Public Health Agencies, Diagnostic Centers, Research & Development Centers, Retail sales, Retail pharmacies/supermarket, Drug store, E-commerce/Online Platform; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : April 2024
  • Report Code : 4176
  • Category : Healthcare

Oral Syringes Market Size and Growth 2024 to 2033

The global oral syringes market size was valued at USD 1.62 billion in 2023 and is anticipated to reach around USD 3.02 billion by 2033, growing at a CAGR of 6.43% from 2024 to 2033. The development of disposable oral syringes could be an opportunity to the growth of the market.

Oral Syringes Market Size 2024 to 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Oral Syringes Market Key Takeaways

  • Asia Pacific dominated the global oral syringes market by region in 2023.
  • North America is expected to grow to the highest CAGR in the market by region during the forecast period.
  • The large-volume syringes segment dominated the market by capacity in 2023.
  • The medium-volume syringes segment is expected to grow at the highest CAGR in the market by capacity during the forecast period.
  • The over-the-counter (OTC)  segment dominated the market by order type in 2023.
  • The institutional sales segment dominated the market by sales channel in 2023.
  • The retail sales segment is expected to grow at the highest CAGR in the market by sales channel during the forecast period.
  • The dental procedures segment dominated the market by application in 2023.
  • The post-surgery/critical care segment is expected to grow to the highest CAGR in the market by application during the forecast period.

Oral Syringes Market Overview

The oral syringes market refers to an oral syringe as a measuring tool that is useful for precisely measuring liquid pharmaceutical dosages expressed in milliliters (ml). The oral syringes don’t have thread tips since the contents are squirted straight from the syringes into the mouth of the person or animal, eliminating the need for a needle or other devices to be screwed onto them. The oral syringes are marketed in various sizes, from 1ml to 10ml and larger. The most common sizes of oral syringes are 1ml, 2.5ml, 3ml, 5ml, and 10ml.

The oral syringes market is fragmented with multiple small-scale and large-scale players, such as Adelphi Healthcare Packaging, Schott AG, Gerresheimer AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., DWK Life Sciences GmbH, Vetter Pharma International GmbH, Comar, LLC, Baxter International Inc., TOPAS Advanced Polymers, Inc., Dentsply Sirona, Septodont, Terumo Corporation, Merit Medical Systems, Inc., Plas-Tech Engineering, B. Braun Melsungen, Medtronic plc, Smiths Medical, Inc., NIPRO Corporation, Integra LifeSciences.

Oral Syringes Market Growth Factors

  • The rising pediatric population may be the driving factor in the oral syringes market.
  • The increasing incidence of chronic diseases in the geriatric population boosts the market.
  • The development of disposable oral syringes could be an opportunity for the growth of the oral syringes market.

Oral Syringes Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 6.43%
Global Market Size in 2023 USD 1.62 Billion
Global Market Size in 2024 USD 1.72 Billion
Global Market Size by 2033 USD 3.02 Billion
Largest Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Capacity, By Order Type, By Sales Channel, and By Application
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Oral Syringes Market Dynamics

Drivers

Rising pediatric population

The rising pediatric population may be the driving factor in the oral syringes market. The market for oral syringes has grown as a result of the increasing number of youngsters who frequently need precise and secure medicine administration, which oral syringes help with. As for administering medication to children, oral syringes are preferable because of their accurate dosage measurement, ease of use, and lower chance of spills as compared to alternative techniques. The need for oral syringes to satisfy the medical needs of children is growing along with the number of children.

As per a journal published by PubMed Central, the majority of children (87.5%) were familiar with oral syringes, yet administration of a different type of formulation (MPs) in an oral syringe was a new experience for both the children and their parents/caregivers.

Increasing incidence of chronic diseases in the geriatric population

The increasing incidence of chronic diseases in the geriatric population boosts the oral syringes market. Chronic diseases are long-term diseases that can endure for years or even a lifetime. So, the increasing incidence of chronic disease in the geriatric population frequently results in trouble in swallowing pills or tablets. The administration of medication with oral syringes is made simpler and safer, which can boost the market.

Restraint

Risk of contamination and infection

The risk of contamination and infection caused by oral syringes can slow down the oral syringes market. This is due to rising concerns about patient safety and hygiene. The contamination may occur due to the syringe not being cleaned after use, which results in the chances of infections.

Opportunity

Development of disposable oral syringes

The development of disposable oral syringes could be an opportunity for the growth of the oral syringes market. This is because disposable oral syringes resolve concerns about contamination and infection risk, and their development offers a chance to expand the oral syringes market. The disposable syringes provide a practical and hygienic option by guaranteeing that a fresh, sterile syringe is used for each dosage. This may boost customer acceptability and confidence, increasing the need for oral syringes and propelling the market's expansion. The disposable syringes can simplify healthcare procedures and may result in lower expenses for healthcare providers by eliminating the need for washing and sterilization.

Capacity Insights

The large-volume syringes segment dominated the oral syringes market by capacity in 2023. The dominance of volume syringes is because they make it easier to measure and deliver medication accurately, especially for a patient who requires higher dosages or for caretakers managing several prescriptions. Large-capacity syringes are the market leader in oral syringes. In addition, they are preferred in a variety of healthcare settings since they frequently have features like measurement markers and simple-to-use plungers.

The medium-volume syringes segment is expected to grow at the highest CAGR in the oral syringes market during the forecast period. The market for oral syringes is anticipated to expand as a result of the medium-volume syringe’s adaptability and compatibility with a variety of drugs and dosages. For many patients and caregivers, they offer the perfect compromise between the ease of use of big-volume syringes and the accuracy of volumes. Furthermore, advanced medium-capacity syringes could result from development in technology and materials, which would increase their commercial acceptance.

Order Type Insights

The over-the-counter (OTC)  segment dominated the oral syringes market by order type in 2023. The market is dominated by over-the-counter (OTC) oral syringes, mainly because of their accessibility and simplicity. OTC products are easily acquired in pharmacies, supermarkets, and internet sellers since they are easily accessible to customers without a prescription. This extensive accessibility is a factor in their market dominance, which is partly attributed to their extensive availability. Furthermore, a wider range of consumers are frequently served by over-the-counter oral syringes, including those who might not have access to prescription drugs or who would rather self-medicate for mild illnesses. Consequently, over-the-counter oral syringes garner a substantial market share in contrast to prescription-only substitutes.

Sales Channels Insights

The institutional sales segment dominated the oral syringes market by sales channel in 2023. This is because institutional sales involve bulk purchases by healthcare facilities, which include hospitals and clinics; they frequently control the market. Because this institution treats a huge number of patients, they are in great demand, which gives suppliers bargaining strength and economies of scale. Institutional sales often place a high priority on safety, dependability, and standardized products, which may favor well-known suppliers and companies with a track record of success.

The retail sales segment is expected to grow at the highest CAGR in the market during the forecast period. This is because as consumers gain more knowledge about healthcare goods, they look for dosing alternatives that are accurate and convenient for both themselves and their families. The more retail sales drugs become available, the more customers need dependable and easy-to-use dosage tools like oral syringes, which are expected to grow the oral syringes market.

Application Insights

The dental procedures segment dominated the oral syringes market by application in 2023. Because dental operations frequently call for exact measurement and administration of drugs or solutions directly into the mouth cavity—a function that oral syringes are intended to enable—they dominate the oral syringe market. These operations involve the delivery of periodontal disease drugs, The application of fluoride treatments, the administration of local anesthetics, and more. Because they provide convenience, control, and accuracy, oral syringes are indispensable instruments in dentistry.

The post-surgery/critical care segment is expected to grow to the highest CAGR in the oral syringes market during the forecast period. Following surgery, dental care and the delivery of medications such as painkillers, antibiotics, and other treatments are common post-operative procedures. In particular, oral syringes are essential for precisely and comfortably administering these medications to individuals who may have restricted mouth sensitivity or mobility following surgery. The need for oral syringes to provide accurate and efficient medicine distribution is anticipated to increase as surgical techniques progress and post-operative care becomes more important, which will fuel the market's growth.

Regional Insights

Asia Pacific dominated the oral syringes market by region in 2023. This is because so many people in the world reside in Asia-Pacific, and there is an increased need for medical supplies and equipment, such as oral syringes.

Asia Pacific economies are expanding, which is driving up the cost of healthcare. This fuels the need for cutting-edge medical equipment, such as oral syringes. The region is seeing an increase in the prevalence of chronic illnesses like diabetes and cardiovascular disease. Patients with these illnesses frequently receive medication by oral syringes, which fuels market expansion.

Oral Syringes Market Share, By Region, 2023 (%)

North America is expected to grow to the highest CAGR in the oral syringes market during the forecast period. The reasons behind this are the aging population, the rising need for oral drugs, improvements in healthcare infrastructure, and an increase in chronic diseases requiring exact dosage administration, which are driving the growth of the market in North America. Additionally, the growth of the market is also supported by the region’s growing pharmaceutical sector and increased healthcare spending.

Oral Syringes Market Recent Developments

  • In November 2023, Hyderabad-based NiedlFree Technologies announced the development of a needle-free oral insulin spray called Ozulin, offering a painless alternative for diabetes treatment. The company has obtained global patents for Ozulin in over 40 countries and has applied for permission to conduct safety studies.
  • In September 2023, Mosie Baby, an Austin-based home fertility solutions manufacturing company, announced the launch of an updated Mosie Baby At-Home Insemination Kit and the successful closing of an oversubscribed bridge round with over $1M in funding.

Oral Syringes Market Companies

  • Adelphi Healthcare Packaging
  • Schott AG
  • Gerresheimer AG
  • Becton, Dickinson, and Company
  • West Pharmaceutical Services, Inc.
  • DWK Life Sciences GmbH
  • Vetter Pharma International GmbH
  • Comar, LLC
  • Baxter International Inc.
  • TOPAS Advanced Polymers, Inc.
  • Dentsply Sirona
  • Septodont
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Plas-Tech Engineering
  • B. Braun Melsungen
  • Medtronic plc
  • Smiths Medical, Inc.
  • NIPRO Corporation
  • Integra LifeSciences

Segment Covered in the Report

By Capacity

  • Small Volume Syringe (1 to 10 ml)
  • Medium Volume Syringe (10 to 20 ml)
  • Large Volume Syringe (above 20ml)

By Order Type

  • OTC (over-the-counter)
  • Prescription

By Sales Channel

  • Institutional Sales
  • Hospitals/Clinics
  • Public Health Agencies
  • Diagnostic Centers
  • Research & Development Centers
  • Retail sales
  • Retail pharmacies/supermarket
  • Drug store
  • E-commerce/Online Platform

By Application

  • Pediatric Care
  • Geriatric Care
  • Post-Surgery/Critical Care
  • Dental Procedures
  • Others (Home Healthcare, Enteral Nutrition)

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The global oral syringes market size is expected to increase USD 3.02 billion by 2033 from USD 1.62 billion in 2023.

The global oral syringes market will register growth rate of 6.43% between 2024 and 2033.

The major players operating in the oral syringes market are Adelphi Healthcare Packaging, Schott AG, Gerresheimer AG, Becton, Dickinson, and Company, West Pharmaceutical Services, Inc., DWK Life Sciences GmbH, Vetter Pharma International GmbH, Comar, LLC, Baxter International Inc., TOPAS Advanced Polymers, Inc, Dentsply Sirona, Septodont, Terumo Corporation, Merit Medical Systems, Inc., Plas-Tech Engineering, B. Braun Melsungen, Medtronic plc, Smiths Medical, Inc., NIPRO Corporation, Integra LifeSciences, and Others.

The driving factors of the oral syringes market are the rising pediatric population and increasing incidence of chronic diseases in the geriatric population.

Asia Pacific region will lead the global oral syringes market during the forecast period 2024 to 2033.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Oral Syringes Market 

5.1. COVID-19 Landscape: Oral Syringes Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Oral Syringes Market, By Capacity

8.1. Oral Syringes Market Revenue and Volume Forecast, by Capacity, 2024-2033

8.1.1. Small Volume Syringe (1 to 10 ml)

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Medium Volume Syringe (10 to 20 ml)

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Large Volume Syringe (above 20ml)

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Oral Syringes Market, By Order Type

9.1. Oral Syringes Market Revenue and Volume Forecast, by Order Type, 2024-2033

9.1.1. OTC (over-the-counter)

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Prescription

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Oral Syringes Market, By Sales Channel 

10.1. Oral Syringes Market Revenue and Volume Forecast, by Sales Channel, 2024-2033

10.1.1. Institutional Sales

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Hospitals/Clinics

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Public Health Agencies

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Diagnostic Centers

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Research & Development Centers

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

10.1.6. Retail sales

10.1.6.1. Market Revenue and Volume Forecast (2021-2033)

10.1.7. Retail pharmacies/supermarket

10.1.7.1. Market Revenue and Volume Forecast (2021-2033)

10.1.8. Drug store

10.1.8.1. Market Revenue and Volume Forecast (2021-2033)

10.1.9. E-commerce/Online Platform

10.1.9.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Oral Syringes Market, By Application 

11.1. Oral Syringes Market Revenue and Volume Forecast, by Application, 2024-2033

11.1.1. Pediatric Care

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Geriatric Care

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Post-Surgery/Critical Care

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. Dental Procedures

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

11.1.5. Others (Home Healthcare, Enteral Nutrition)

11.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Oral Syringes Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Capacity (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Order Type (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

Chapter 13. Company Profiles

13.1. Adelphi Healthcare Packaging

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Schott AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Gerresheimer AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Becton, Dickinson, and Company

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. West Pharmaceutical Services, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. DWK Life Sciences GmbH

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Vetter Pharma International GmbH

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Comar, LLC

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Baxter International Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. TOPAS Advanced Polymers, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client